A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system

被引:168
作者
Zhang, Qianyu [1 ]
Tang, Jie [1 ]
Fu, Ling [1 ]
Ran, Rui [1 ]
Liu, Yayuan [1 ]
Yuan, Mingqing [1 ]
He, Qin [1 ]
机构
[1] Sichuan Univ, West China Sch Pharm, Key Lab Drug Targeting & Drug Delivery Syst, Chengdu 610041, Peoples R China
基金
中国国家自然科学基金;
关键词
TH; pH-responsive alpha-helical cell penetrating; peptide; Liposome; Paclitaxel; C26 tumor model; NONVIRAL GENE DELIVERY; DRUG-DELIVERY; HYALURONIC-ACID; SOLID TUMOR; PACLITAXEL; CANCER; NANOPARTICLES; MECHANISM; EFFICACY; MICELLES;
D O I
10.1016/j.biomaterials.2013.07.014
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Tumor-oriented nanocarrier drug delivery approaches with pH-sensitivity have been drawing considerable attentions over the years. Here we described a liposomal delivery system modified with pH-responsive cell penetrating peptide TH (TH-Lip). Conventional cell penetrating peptide (CPP)-related drug delivery tactics sometimes seemed limited due to the extensive in vivo penetration and the lack of proper selectivity of conventional CPPs. In this study, TH (AGYLLGHINLHHLAHL(Aib)HHIL-NH2), an engineered alpha-helical cell penetrating peptide originated from peptide TK (AGYLLGKINLKKLAKL(Aib)LLIL-NH2), was endowed pH-responsiveness after complete replacement of all lysines in the sequence of TIC into histidines, and was introduced onto the surface of liposomes. Accordingly, TH-Lip could benefit from the unique property of TH, as the cell penetrating capacity of TH was concealed during the blood circulation and in normal tissues because of the neutral pH under those conditions. However, when TH-Lip reached the tumor, and as pH declined, histidines in TH peptide protonated and the surface charge of TH-Lip converted from negative to positive, initiating activated cell penetrating capacity and leading to enhanced cellular and tumor spheroid uptake. The endocytosis inhibition assay demonstrated that the endocytosis of TH-Lip was influenced by the positively charged surface of the liposomes in acidic environment and was mediated by clathrin, and the intracellular trafficking study suggested that the liposomes were mainly accumulated in endoplasmic reticulum and Golgi apparatus. After systemic administration in mice, TH-Lip could be internalized into tumor cells efficaciously. When it comes to the delivery of paclitaxel (PTX), the pH-responsiveness of TH-Lip led to strong inhibition against tumor cell growth which occurred both in vitro (under pH 6.3) and in vivo, and the tumor inhibition rate reached 86.3% on C26 tumor-bearing mice for PTX-loaded TH-Lip. Therefore, TH-Lip proved itself to be a promising pH-responsive strategy for drug delivery within acidified tumor microenvironment. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:7980 / 7993
页数:14
相关论文
共 52 条
[1]   Emerging links between surface nanotechnology and endocytosis: Impact on nonviral gene delivery [J].
Adler, Andrew F. ;
Leong, Kam W. .
NANO TODAY, 2010, 5 (06) :553-569
[2]   Liposomal drug delivery systems: From concept to clinical applications [J].
Allen, Theresa M. ;
Cullis, Pieter R. .
ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (01) :36-48
[3]   Differential membrane perturbation caused by the cell penetrating peptide Tp10 depending on attached cargo [J].
Barany-Wallje, Elsa ;
Gaur, Jugnu ;
Lundberg, Pontus ;
Langel, Ulo ;
Graslund, Astrid .
FEBS LETTERS, 2007, 581 (13) :2389-2393
[4]   Doxil® - The first FDA-approved nano-drug: Lessons learned [J].
Barenholz, Yechezkel .
JOURNAL OF CONTROLLED RELEASE, 2012, 160 (02) :117-134
[5]   Raman Microscopy for Noninvasive Imaging of Pharmaceutical Nanocarriers: Intracellular Distribution of Cationic Liposomes of Different Composition [J].
Chernenko, T. ;
Sawant, R. R. ;
Miljkovic, M. ;
Quintero, L. ;
Diem, M. ;
Torchilin, V. .
MOLECULAR PHARMACEUTICS, 2012, 9 (04) :930-936
[6]   Tumor-Specific Anti-Nucleosome Antibody Improves Therapeutic Efficacy of Doxorubicin-Loaded Long-Circulating Liposomes against Primary and Metastatic Tumor in Mice [J].
ElBayoumi, Tamer A. ;
Torchilin, Vladimir P. .
MOLECULAR PHARMACEUTICS, 2009, 6 (01) :246-254
[7]   Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and their stability in simulated gastric conditions [J].
Ezzat, Kariem ;
Zaghloul, Eman M. ;
Andaloussi, Samir E. L. ;
Lehto, Taavi ;
El-Sayed, Ramy ;
Magdy, Tarek ;
Smith, C. I. Edvard ;
Langel, Ulo .
JOURNAL OF CONTROLLED RELEASE, 2012, 162 (01) :1-8
[8]   Bubble Liposomes and Ultrasound Enhance the Antitumor Effects of AG73 Liposomes Encapsulating Antitumor Agents [J].
Hamano, Nobuhito ;
Negishi, Yoichi ;
Omata, Daiki ;
Takahashi, Yoko ;
Manandhar, Maya ;
Suzuki, Ryo ;
Maruyama, Kazuo ;
Nomizu, Motoyoshi ;
Aramaki, Yukihiko .
MOLECULAR PHARMACEUTICS, 2013, 10 (02) :774-779
[9]   Emerging nanomaterials for targeting subcellular organelles [J].
Huang, Jasper G. ;
Leshuk, Timothy ;
Gu, Frank X. .
NANO TODAY, 2011, 6 (05) :478-492
[10]  
Huang Y, 2013, ADV DRUG DELIV REV, DOI DOI 10.1016/1.ADDR.2012.11.007